These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37873106)

  • 1. G6PD Maintains Redox Homeostasis and Biosynthesis in LKB1-Deficient KRAS-Driven Lung Cancer.
    Lan T; Arastu S; Wang S; Lam J; Wang W; Bhatt V; Lopes EC; Hu Z; Sun M; Luo X; Ghergurovich JM; Li C; Su X; Rabinowitz JD; White E; Guo JY
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancer.
    Lan T; Arastu S; Lam J; Kim H; Wang W; Wang S; Bhatt V; Lopes EC; Hu Z; Sun M; Luo X; Ghergurovich JM; Su X; Rabinowitz JD; White E; Guo JY
    Nat Commun; 2024 Jul; 15(1):5857. PubMed ID: 38997257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of autophagy and MEK promotes ferroptosis in Lkb1-deficient Kras-driven lung tumors.
    Bhatt V; Lan T; Wang W; Kong J; Lopes EC; Wang J; Khayati K; Raju A; Rangel M; Lopez E; Hu ZS; Luo X; Su X; Malhotra J; Hu W; Pine SR; White E; Guo JY
    Cell Death Dis; 2023 Jan; 14(1):61. PubMed ID: 36702816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLC.
    Zhang H; Nabel CS; Li D; O'Connor RÍ; Crosby CR; Chang SM; Hao Y; Stanley R; Sahu S; Levin DS; Chen T; Tang S; Huang HY; Meynardie M; Stephens J; Sherman F; Chafitz A; Costelloe N; Rodrigues DA; Fogarty H; Kiernan MG; Cronin F; Papadopoulos E; Ploszaj M; Weerasekara V; Deng J; Kiely P; Bardeesy N; Vander Heiden MG; Chonghaile TN; Dowling CM; Wong KK
    J Thorac Oncol; 2023 Jul; 18(7):882-895. PubMed ID: 36958689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of non-small cell lung cancer (NSCLC) proliferation through targeting G6PD.
    Chanda M; Anuntasomboon P; Ruangritchankul K; Cheepsunthorn P; Cheepsunthorn CL
    PeerJ; 2023; 11():e16503. PubMed ID: 38077440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.
    Ghergurovich JM; Esposito M; Chen Z; Wang JZ; Bhatt V; Lan T; White E; Kang Y; Guo JY; Rabinowitz JD
    Cancer Res; 2020 Sep; 80(18):3820-3829. PubMed ID: 32661137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer.
    Kim J; Lee HM; Cai F; Ko B; Yang C; Lieu EL; Muhammad N; Rhyne S; Li K; Haloul M; Gu W; Faubert B; Kaushik AK; Cai L; Kasiri S; Marriam U; Nham K; Girard L; Wang H; Sun X; Kim J; Minna JD; Unsal-Kacmaz K; DeBerardinis RJ
    Nat Metab; 2020 Dec; 2(12):1401-1412. PubMed ID: 33257855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting focal adhesion kinase boosts immune response in KRAS/LKB1 co-mutated lung adenocarcinoma via remodeling the tumor microenvironment.
    Qiao M; Zhou F; Liu X; Jiang T; Wang H; Li X; Zhao C; Cheng L; Chen X; Ren S; Wang Z; Zhou C
    Exp Hematol Oncol; 2024 Jan; 13(1):11. PubMed ID: 38291516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition.
    Ding H; Chen Z; Wu K; Huang SM; Wu WL; LeBoeuf SE; Pillai RG; Rabinowitz JD; Papagiannakopoulos T
    Sci Adv; 2021 Nov; 7(47):eabk1023. PubMed ID: 34788087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.
    Sun Y; Gu X; Zhang E; Park MA; Pereira AM; Wang S; Morrison T; Li C; Blenis J; Gerbaudo VH; Henske EP; Yu JJ
    Cell Death Dis; 2014 May; 5(5):e1231. PubMed ID: 24832603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells.
    Kim J; Hu Z; Cai L; Li K; Choi E; Faubert B; Bezwada D; Rodriguez-Canales J; Villalobos P; Lin YF; Ni M; Huffman KE; Girard L; Byers LA; Unsal-Kacmaz K; Peña CG; Heymach JV; Wauters E; Vansteenkiste J; Castrillon DH; Chen BPC; Wistuba I; Lambrechts D; Xu J; Minna JD; DeBerardinis RJ
    Nature; 2017 Jun; 546(7656):168-172. PubMed ID: 28538732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden.
    Salehi-Rad R; Li R; Tran LM; Lim RJ; Abascal J; Momcilovic M; Park SJ; Ong SL; Shabihkhani M; Huang ZL; Paul M; Shackelford DB; Krysan K; Liu B; Dubinett SM
    Cancer Immunol Immunother; 2021 Aug; 70(8):2389-2400. PubMed ID: 33507343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETS1 regulates Twist1 transcription in a Kras
    Millien G; Cao Y; O'Hara CJ; Tagne JB; Hinds A; Williams MC; Ramirez MI; Kathuria H
    Clin Exp Metastasis; 2018 Mar; 35(3):149-165. PubMed ID: 29909489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response.
    Li F; Han X; Li F; Wang R; Wang H; Gao Y; Wang X; Fang Z; Zhang W; Yao S; Tong X; Wang Y; Feng Y; Sun Y; Li Y; Wong KK; Zhai Q; Chen H; Ji H
    Cancer Cell; 2015 May; 27(5):698-711. PubMed ID: 25936644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In Vivo.
    Dong LH; Li L; Song Y; Duan ZL; Sun SG; Lin YL; Miao SB; Yin YJ; Shu YN; Li H; Chen P; Zhao LL; Han M
    Circ Res; 2015 Sep; 117(8):684-94. PubMed ID: 26291555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-6-phosphate dehydrogenase deficiency accelerates pancreatic acinar-to-ductal metaplasia.
    Radyk MD; Nelson BS; Halbrook CJ; Wood A; Lavoie B; Salvatore L; Corfas G; Colacino JA; Shah YM; Crawford HC; Lyssiotis CA
    bioRxiv; 2023 Nov; ():. PubMed ID: 37986898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Linkage and Correlations to Storage Capacity in Erythrocytes from Glucose 6-Phosphate Dehydrogenase-Deficient Donors.
    Reisz JA; Tzounakas VL; Nemkov T; Voulgaridou AI; Papassideri IS; Kriebardis AG; D'Alessandro A; Antonelou MH
    Front Med (Lausanne); 2017; 4():248. PubMed ID: 29376053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G6PD-mediated increase in de novo NADP
    Zhang Y; Xu Y; Lu W; Li J; Yu S; Brown EJ; Stanger BZ; Rabinowitz JD; Yang X
    Sci Adv; 2022 Jul; 8(29):eabo0404. PubMed ID: 35857842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid phosphorylation of glucose-6-phosphate dehydrogenase by casein kinase 2 sustains redox homeostasis under ionizing radiation.
    Hao Y; Ren T; Huang X; Li M; Lee JH; Chen Q; Liu R; Tang Q
    Redox Biol; 2023 Sep; 65():102810. PubMed ID: 37478541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.